TIAA CREF Investment Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$32.8M Sell
883,233
-2,291,881
-72% -$83.4M 0.02% 518
2018
Q4
$89.6M Buy
3,175,114
+1,979,354
+166% +$62.6M 0.07% 267
2018
Q3
$47.2M Sell
1,195,760
-87,596
-7% -$3.83M 0.03% 454
2018
Q2
$56.9M Buy
1,283,356
+273,375
+27% +$13.6M 0.04% 412
2018
Q1
$49.2M Sell
1,009,981
-2,318,239
-70% -$116M 0.03% 444
2017
Q4
$167M Buy
3,328,220
+674,071
+25% +$35.3M 0.11% 192
2017
Q3
$134M Buy
2,654,149
+865,037
+48% +$40.8M 0.09% 227
2017
Q2
$67.8M Buy
1,789,112
+999,380
+127% +$39.4M 0.05% 378
2017
Q1
$30.4M Buy
789,732
+27,818
+4% +$837K 0.02% 596
2016
Q4
$16.8M Buy
761,914
+200,133
+36% +$4.11M 0.01% 825
2016
Q3
$8.99K Sell
561,781
-12,602
-2% -$144K 0.01% 1194
2016
Q2
$4.73M Buy
574,383
+275,066
+92% +$2.45M ﹤0.01% 1575
2016
Q1
$2.1M Buy
299,317
+3,579
+1% +$18K ﹤0.01% 2041
2015
Q4
$1.58M Sell
295,738
-34,469
-10% -$220K ﹤0.01% 2298
2015
Q3
$2.14M Buy
+330,207
New +$3.46M ﹤0.01% 2097

Other funds holding CC

TIAA CREF Investment Management's CC Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Chemours (CC) stake by 72% in Q1 2019, selling an estimated $83.4M and leaving 883,233 shares worth $32.8M. The position accounts for 0.02% of the portfolio, ranked #518.

TIAA CREF Investment Management first reported a position in CC in Q3 2015 and has held it in 15 quarters since. The position peaked at $167M in Q4 2017. 539 funds tracked by Wall St. Rank hold CC as of Q1 2019.

  • TIAA CREF Investment Management held 883,233 shares of Chemours worth $32.8M as of Q1 2019.
  • TIAA CREF Investment Management sold 2,291,881 Chemours shares in Q1 2019, an estimated $83.4M.
  • Chemours made up 0.02% of TIAA CREF Investment Management's portfolio in Q1 2019, its #518 holding.
  • TIAA CREF Investment Management first reported a position in Chemours in Q3 2015 and has held it in 15 quarters since.
  • TIAA CREF Investment Management's Chemours position peaked at $167M in Q4 2017.
  • 539 funds tracked by Wall St. Rank held Chemours as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.